OBIO · ISSUER CIK 1814114
Orchestra BioMed Holdings, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 8 Orchestra BioMed Holdings, Inc. insiders reported $59K of open-market purchases and $231K of sales on SEC Form 4. The largest buyer was Hochman David P (See Remarks, Director), with $48K.
↗8 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 3 of 3 sales were reported under a 10b5-1 plan.
$59KInsider buying
$231KInsider selling
−$172KNet open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:30 | Oct 1, 2026 | OBIO | See Remarks, Director | S · Sell10b5-1 | $6.36 | −15,000 | 1,119,402 | -1% | −$95K | ||
| Sep 11, 202618:11 | Sep 10, 2026 | OBIO | See Remarks, Director | F · Tax | $5.81 | −6,566 | 1,067,463 | -1% | $38K | ||
| Sep 8, 202608:15 | Sep 3, 2026 | OBIO | See Remarks, Director | P · BuyLate 5d | $4.79 | +10,000 | 1,070,746 | +1% | +$48K | -15.4% | +25.1% |
| Sep 2, 202616:15 | Sep 1, 2026 | OBIO | See Remarks, Director | S · Sell10b5-1 | $4.94 | −15,000 | 1,134,402 | -1% | −$74K | ||
| Aug 28, 202616:16 | Aug 26, 2026 | OBIO | Chief Financial Officer | F · Tax | $5.26 | −3,076 | 589,989 | -1% | $16K | ||
| Aug 28, 202616:15 | Aug 26, 2026 | OBIO | See Remarks, Director | P · Buy | $5.33 | +2,000 | 2,000 | New | +$11K | -5.8% | +12.4% |
| Aug 28, 202616:15 | Aug 26, 2026 | OBIO | See Remarks, Director | F · Tax | $5.26 | −4,925 | 1,149,402 | -0% | $26K | ||
| Aug 28, 202616:15 | Aug 26, 2026 | OBIO | Principal Accounting Officer | F · Tax | $5.26 | −203 | 18,441 | -1% | $1K | ||
| Aug 14, 202616:17 | Aug 12, 2026 | OBIO | Director | F · Tax | $4.42 | −3,761 | 54,750 | -6% | $17K | ||
| Aug 14, 202616:16 | Aug 12, 2026 | OBIO | Director | F · Tax | $4.42 | −5,145 | 99,630 | -5% | $23K | ||
| Aug 14, 202616:15 | Aug 12, 2026 | OBIO | Director | F · Tax | $4.42 | −4,885 | 66,544 | -7% | $22K | ||
| Aug 14, 202616:15 | Aug 12, 2026 | OBIO | Director | F · Tax | $4.42 | −4,238 | 29,153 | -13% | $19K | ||
| Aug 4, 202616:49 | Aug 3, 2026 | OBIO | See Remarks, Director | S · Sell10b5-1 | $4.09 | −15,000 | 1,154,327 | -1% | −$61K |